Fifty percent of patients with adenomyosis have a combination of fibroids. The main symptoms of this group of patients are dysmenorrhea and excessive menstrual flow, and the symptoms are mainly dysmenorrhea. The main purpose of interventional treatment for fibroids is to block the blood supply to the fibroids through embolization, thus stopping the growth or necrosis of the fibroids and achieving treatment. The treatment of adenomyosis is also based on ischemia and necrosis of the adenomyosis lesion by interventional methods, resulting in clinical pain relief and reduction of menstrual flow. Therefore, the interventional treatment of both diseases is similar, but the treatment is really different. Our clinical experience is that for uterine fibroids, only temporary blockage of the blood supply to the fibroids is needed to achieve the treatment purpose, while adenomyosis requires a higher embolization scope and degree, therefore, the embolization materials and embolization techniques needed for both are different, and the requirements for adenomyosis are a bit higher. The requirements are a bit higher in adenomyosis. When both diseases are present, the technical requirements for uterine fibroids are lower than those for adenomyosis, so that the interventional treatment of both diseases can be achieved by using the requirements for interventional treatment of adenomyosis.